Page last updated: 2024-10-29

isradipine and Brain Infarction

isradipine has been researched along with Brain Infarction in 1 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Brain Infarction: Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.

Research Excerpts

ExcerptRelevanceReference
" Practically identical isradipine dose-response neuroprotection curves were observed for both measurement procedures."1.35Brain MRI and neurological deficit measurements in focal stroke: rapid throughput validated with isradipine. ( Barone, FC; Chandra, S; Lenhard, SC; Price, WJ; Strittmatter, R; White, RF, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lenhard, SC1
Strittmatter, R1
Price, WJ1
Chandra, S1
White, RF1
Barone, FC1

Other Studies

1 other study available for isradipine and Brain Infarction

ArticleYear
Brain MRI and neurological deficit measurements in focal stroke: rapid throughput validated with isradipine.
    Pharmacology, 2008, Volume: 81, Issue:1

    Topics: Animals; Behavior, Animal; Brain Infarction; Calcium Channel Blockers; Disease Models, Animal; Israd

2008